Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein
- PMID: 2110977
Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein
Abstract
Effects of the K+ channel blocking agent, glyburide, on the actions of two K+ channel openers, BRL 34915 (cromakalim) and P 1060 (Leo), a potent pinacidil derivative (N-(t-butyl)-N"-cyano-N'-3-pyridyl-guanidine), were ascertained. Tension responses and 86Rb fluxes in rat portal vein strips and single channel electrophysiological recordings in enzymatically dissociated rat portal vein cells were obtained. Glyburide (0.3 microM) increased spontaneous contractile activity and caused concentration-dependent shifts in the relaxation responses to BRL 34915 and P 1060. Increases in 86Rb efflux were obtained only at much higher concentrations of BRL 34915 or P 1060, and these increases were blocked only at higher concentrations of glyburide (5.0 microM). BRL 34915 and P 1060 specifically increase the open-state probability of the Ca+(+)-activated K+ (maxi-K+) channel, and these actions are blocked by glyburide and also by charybdotoxin. Changes in single channel activity and contractile responsiveness occur at similar concentrations of agonists and antagonists. Thus, the membrane channel in rat portal vein affected by glyburide, BRL 34915 and P 1060 appears to be the Ca+(+)-activated maxi-K+ channel (that does not show ATP dependence under the conditions of these experiments). Concentrations of agonists and antagonists effective on maxi-K+ channel activity correspond to those affecting contractile responsiveness and are lower than those eliciting changes in 86Rb flux.
Similar articles
-
Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.J Pharmacol Exp Ther. 1990 May;253(2):586-93. J Pharmacol Exp Ther. 1990. PMID: 2160002
-
In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.J Pharmacol Exp Ther. 1989 Jul;250(1):261-71. J Pharmacol Exp Ther. 1989. PMID: 2501478
-
Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.Proc West Pharmacol Soc. 1992;35:97-102. Proc West Pharmacol Soc. 1992. PMID: 1502246 No abstract available.
-
The potassium channel openers: a new class of vasorelaxants.Blood Vessels. 1990;27(2-5):306-13. doi: 10.1159/000158823. Blood Vessels. 1990. PMID: 1700735 Review.
-
K(+)-channel openers: new antihypertensive drugs?Clin Physiol Biochem. 1990;8 Suppl 2:46-56. Clin Physiol Biochem. 1990. PMID: 2095310 Review.
Cited by
-
Calcium-activated potassium channels in native endothelial cells from rabbit aorta: conductance, Ca2+ sensitivity and block.J Physiol. 1992 Sep;455:601-21. doi: 10.1113/jphysiol.1992.sp019318. J Physiol. 1992. PMID: 1484364 Free PMC article.
-
Potassium channel modulation in rat portal vein by ATP depletion: a comparison with the effects of levcromakalim (BRL 38227).Br J Pharmacol. 1992 Dec;107(4):945-55. doi: 10.1111/j.1476-5381.1992.tb13390.x. Br J Pharmacol. 1992. PMID: 1467843 Free PMC article.
-
Differences in the K(+)-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery.Br J Pharmacol. 1991 Mar;102(3):585-94. doi: 10.1111/j.1476-5381.1991.tb12217.x. Br J Pharmacol. 1991. PMID: 1285396 Free PMC article.
-
Comparison of the actions of acetylcholine and BRL 38227 in the guinea-pig coronary artery.Br J Pharmacol. 1992 May;106(1):9-16. doi: 10.1111/j.1476-5381.1992.tb14285.x. Br J Pharmacol. 1992. PMID: 1504734 Free PMC article.
-
Effects of P1060 and aprikalim on whole-cell currents in rat portal vein; inhibition by glibenclamide and phentolamine.Br J Pharmacol. 1993 Apr;108(4):991-8. doi: 10.1111/j.1476-5381.1993.tb13496.x. Br J Pharmacol. 1993. PMID: 8485637 Free PMC article.